Common Carotid Artery Occlusion Treatment: Revealing a Gap in the Current Guidelines  by Klonaris, C. et al.
REVIEWCommon Carotid Artery Occlusion Treatment: Revealing a Gap in the
Current Guidelines
C. Klonaris, G.N. Kouvelos *, M. Kafeza, A. Koutsoumpelis, A. Katsargyris, C. Tsigris
1st Department of Surgery e Division of Vascular Surgery, Laiko General Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece* Co
Athens
E-ma
1078
Surgery
http:WHAT THIS PAPER ADDS
Most of the literature has been concentrated on the internal carotid artery disease with little focus on the
common carotid artery (CCA). Current guidelines do not refer speciﬁcally to CCA occlusion (CCAO), overlooking
that aspect of carotid artery disease. This review is the ﬁrst attempt to reﬂect on the bulk of the current data on
surgical management of CCAO. We show that open surgical management of symptomatic CCA occlusive disease
is a safe, durable, and effective therapeutic strategy with low perioperative cerebrovascular morbidity. This
review supports the need for a larger, multicenter registry to reveal the best treatment for the CCA occlusive
disease.Objective: To review the literature on the management of common carotid artery occlusion (CCAO).
Methods: A review of English-language medical literature from 1965 to 2012 was conducted using the PubMed
and EMBASE databases to ﬁnd all studies involving management of CCAO. The search identiﬁed 21 articles
encompassing 146 patients/arteries (73.2% men; mean age 65  6.9 years).
Results: The majority of the patients (93.8%) were symptomatic. Most of the patients (61.5%) had ipsilateral
internal carotid artery (ICA) and external carotid artery (ECA) patent, while an occluded ICA and a patent ECA
were found in 26.6% of the patients. Eighty per cent of the patients treated underwent a surgical bypass
procedure, with the subclavian artery as the most common inﬂow vessel (64.1%). During the ﬁrst 30 days of the
procedure two strokes (1.5%) were reported. During a follow-up period spanning an average of 25.6  11.2
months nine patients (6.6%) experienced a clinical cerebrovascular event. Seven restenoses (5.1%) and two
reocclusions (1.5%) also occurreddeight after open surgical and one after endovascular repair.
Conclusion: The necessity to intervene to a CCAO remains controversial. This review shows that open surgical
management of symptomatic CCA occlusive disease is a safe, durable, and effective therapeutic strategy with low
perioperative cerebrovascular morbidity.
 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Extracranial carotid circulation and its relationship with the
neurologic system have been thoroughly studied over the
last few decades.1 Most of the research has been concen-
trated on internal carotid artery (ICA) disease, with sparse
focus on the common carotid artery (CCA). CCA total oc-
clusion (CCAO) is a relatively rare condition presenting in
2e4% of patients undergoing angiography for symptomatic
cerebrovascular disease.2,3
CCAO can be associated with a variety of neurologic
symptoms and a risk of stroke. These symptoms may be due
mainly to low cerebral perfusion or, less likely, to recurrentrresponding author. G.N. Kouvelos, Ippokrinis 8-10, 15773 Zografou,
, Greece.
il address: geokouv@gmail.com (G.N. Kouvelos).
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//dx.doi.org/10.1016/j.ejvs.2013.06.006emboli carried to the brain from the carotid stump.2 The
2011 American Heart Association/Society for Vascular Sur-
gery guidelines recommend “revascularization for patients
with symptomatic ischemia involving the anterior cerebral
circulation caused by common carotid or brachiocephalic
artery occlusive disease”, without, however, referring to
CCAO speciﬁcally or discussing any case of CCAO indepen-
dently.4 The 2009 European Society for Vascular Surgery
guidelines do not include any recommendation referring to
CCAO, overlooking that aspect of carotid artery disease.1
There is no clear consensus on the role of invasive
treatment of the CCAO, whether it should be applied in
symptomatic or asymptomatic patients, or which thera-
peutic modality should be selected. The natural history of
the disease is unknown and therefore certain parameters,
such as distal vessel patency and the presence of symp-
toms, may affect the treatment decision. Open surgical or
endovascular procedures have been reported for treating
CCAO without, however, leading to any deﬁnite conclusion.
Figure 2. Rile’s classiﬁcation of common carotid artery occlusion.
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of total CCAO in order to summarize the cumulative expe-
rience to date. Our aim is to determine whether invasive
treatment of CCAO has a clinical beneﬁt, and to discuss the
indications and the treatment options of such a therapeutic
strategy.
METHODS
The study was approved by our institutional review com-
mittee. A review was conducted of the English-language
medical literature from 1965 to December 2012 using the
PubMed and EMBASE databases to ﬁnd all studies involving
management of common carotid artery occlusion. Search
terms included “carotid” or “common”, “occlusion” and
“repair”. Further articles were identiﬁed via examination of
the references cited in the initially identiﬁed reports. Case
series and case reports were included. We excluded any
study that involved cases with concomitant procedures on
the aortic arch, did not provide data separately for CCAO
repair, or did not specify outcome data.
Data were independently extracted and veriﬁed by two
authors (G.K. and A. K.). The search of the electronic
bibliographic sources initially identiﬁed 2980 articles
(Fig. 1). After excluding articles whose titles had no rele-
vance to the area of concern of this review, the full texts of
28 articles were retrieved and assessed for eligibility. The
manual search of the reference list of the selected articles
added another two citations.3,5e33 Nine articles were
excluded because they did not provide data separately for
the patients treated for CCAO.24e33 The following variables
were extracted from each article: age, sex, indication of
treatment, angiographic ﬁndings, periprocedure stroke rate
(within 30 days), technical success, procedural complica-
tions, resolution of symptoms, any cerebrovascular event
during the clinical follow-up period, and mortality. Reste-
nosis was deﬁned as reduction of >50% in diameter.
Angiographic ﬁndings were further categorized into four
types according to the classiﬁcation proposed by Riles et al.
(Fig. 2):11 type 1A involves a patent ICA and ECA; type 1B aFigure 1. Literature search strategy. Note. CCAO ¼ common ca-
rotid artery occlusion.patent ECA and an occluded ICA; type 1C a patent ICA and
an occluded ECA; type 2 involves a total CCA, ICA and ECA
occlusion.11
RESULTS
Twenty-one published studies describing revascularization
procedures in CCAO in a total of 146 patients and 146 ar-
teries were identiﬁed (Table 1). The patients’ mean age was
65  6.9 years (range 41e76 years). Men made up 73.2% of
the patients and there was a left-to-right ratio of 1.36:1.00.
Symptoms
The majority of the patients (138, 94.5%) were symptom-
atic. The precise indication was available in 83 patients and
included transient ischemic attacks in 48 (57.8%) patients,
acute stroke in 20 (24.1%) patients, and non-hemispheric
symptoms of circulatory insufﬁciency in 15 (18.1%) pa-
tients. A total of eight of 146 (5.5%) patients treated had no
symptoms related to CCAO. In this group the interventions
were performed “prophylactically” in ﬁve patients with
ipsilateral CCAO and ipsilateral ICA stenosis >70% or
contralateral ICA occlusion before an aortic surgical proce-
dure in two patients, while indication data were insufﬁcient
in one patient.
Diagnosis: Rile’s classiﬁcation
Digital subtraction angiography (DSA) was performed in all
patients preoperatively. Detailed data for the patency of
distal vessels were available in 109 patients. Most patients
(67, 61.5%) had the ipsilateral ICA and ECA patent (Riles
type IA), while a patent ipsilateral ECA and an occluded ICA
(type 1B) were found in 29 (26.6%) patients. Only 13
(11.9%) of the patients had the ipsilateral ICA and ECA
occluded (type 2). None of the patients had the ipsilateral
ECA occluded and the ICA patent (type 1C).
Intervention
One hundred and thirty-seven of the 146 patients eventu-
ally underwent a revascularization procedure. Nine patients
reported in the original series by Riles et al.11 were not
revascularized as they were found during surgical explora-
tion to suffer from type 2 CCAO and were characterized as
inoperable. The procedures included 114 (83.2%) surgical
bypasses, 15 (10.9%) endarterectomies (13 in the tradi-
tional manner and two remote endarterectomies), seven
Table 1. Summary of common carotid artery occlusion management of patients analyzed in this review.
Author
(year)
n Age,y/sex Indication Angiography Management Follow-up
(months)
Complication
Linni et al.
(2011)5
17 NA Symptomatic 12
Asymptomatic 5
12 Lt
5 Rt
Riles NA
6 CCA to SA transposition
10 SA to CCA bypass
1 retrograde ring-stripper
endarterectomy
50.5 1 high-grade
stenosis 19 m
after transposition
Shirazi et al.
(2011)6
1 67/F TIA Lt (1A) Ligation of ECA, ECA to
ICA anastomosis
6.0 None
Schneider
et al. (2010)24
2 68/M
56/F
1. Stroke
2. Stroke
Rt (2)
Lt (2)
VA to MCA bypass
(radial artery)
2.0 None
Takagi et al.
(2010)23
1 64/M Stroke Bilateral, Rt VA
occlusion (1A)
Stenting with balloon
protection device
12.0 Asymptomatic
in-stent restenosis
9 m, PTA
Inoue et al.
(2008)22
2 65/M
75/M
1. Stroke
2. Impaired
memory
1. Rt (1B)
2. Rt (1A)
1.CCA endarterectomy
2.CCA endarterectomy
17.0
6.0
None
Schubert et al.
(2008)21
1 61/M TIA Lt (1A) SA to ICA bypass (vein) 6.0 None
Pinter et al.
(2007)20
1 60/F TIA Rt (1A) CCA remote
endarterectomy
12.0 None
Crome et al.
(2007)7
1 55/M Stroke Lt (1A) SA to CCA bypass
(Dacron)
NA None
Rabb et al.
(2005)19
1 52/M TIA Lt, Lt ICA
occlusion (1B)
SA to ECA bypass (vein) 96.0 None
Melgar and
Weinand
(2003)18
3 41/M
76/M
67/M
1. Circulatory
insufﬁciency
2. TIA
3. TIA
1. Bil (1B)
2. Rt (1A)
3. Rt (1B)
Thyreocervical trunk
to ECA (all veins)
3.0
12.0
1.0
None
Archie
(1999)10
23 NA All symptomatic 8 (1B)
15 (1A)
11 Ax to ICA bypass
(all vein)
4 Ax to CCA bypass
(3 vein-1 Dacron)
8 Ax to ECA bypass
(7 vein-1 PTFE)
Mean 54.0 1 perioperative
stroke, 3 restenosis
Kobayashi
et al. (1999)13
2 57/M
67/M
2 TIAs 1.Rt (1B)
2. Lt (1B)
2 transverse cervical
bypass pedicle
NA None
Nasagawa
et al. (1996)17
1 67/M Syncope
episodes
Lt (1A) ECA to ECA bypass
with contralateral
CEA (vein)
12.0 None
Sullivan
(1996)12
9 Mean
58.4/6 M
5 TIAs, 2
Stroke, 2
circulatory
insufﬁciency
7 Lt (1A)
2 Rt (1A)
SA to carotid
bifurcation bypass
(5 vein, 4 synthetic)
Mean
37.1
2 patients’ (TIAs)
symptoms recurred
at 21 and 36 m,
both proximal
anastomosis
stenosis, 1 patient
had revision and
occluded 18 m
later; 1 patient
refused
Belkin et al.
(1993)8
6 Mean
61 y/4 M
5 TIAs, 1
circulatory
insufﬁciency
Lt, All 1A 2 SA to CCA bypass
(PTFE)
1 CCA endarterectomy
2 Ax to CCA bypass
(1 vein, 1 PTFE)
1 aorta to CCAs
bif-graft (Dacron)
Mean 66.0 1 perioperative
hyperperfusion
syndrome, 1
symptomatic graft
failure (re-op) at
6e12 years, 1 TIA
at 1 year after, 1
TIA at year 7 after
(both patients
with TIAs patent
grafts)
Continued
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Table 1-continued
Author
(year)
n Age,y/sex Indication Angiography Management Follow-up
(months)
Complication
Martin et al.
(1993)14
8 Mean
64/6 M
2 TIAs, 2 stroke,
2 transient non-
hemispheric, 2
asymptomatic
4 Rt
4 Lt
6 1A, 2 1B
1 SA to ECA (vein)
4 SA to carotid
bifurcation (veins)
1 CCA to carotid
bifurcation (veins)
2 CCA to ICA (veins)
44.0 1 death of stroke
at year 8
1 TIA at 2 years
(with patent graft)
1 stroke at month
4 (graft patent)
Fry et al.
(1992)15
20 Mean
60 y/14 M
19 symptomatic,
1 asymptomatic
11 Rt
9 Lt
5 SA to ECA bypass
6 SA to ICA bypass
9 SA to CCA
(bifurcation)
bypass
4 CEAs, 15 prosthetics,
5 veins
Mean 50.0 1 post-op
death (MI)
Stroke 103 m
(patent graft)
McGuiness
et al. (1988)16
9 Mean
62 y/5 M
7 TIAs, 2
circulatory
insufﬁciency
6 Rt
3 Lt
7 1A, 2 type 2
9 SA to ECA bypass
5 veins, 4 synthetic
Mean 11.2 None
Riles et al.
(1983)11
24 NA/18 M 17 TIAs,
7 stroke
12 Rt
12 Lt
11 1A, 4 1B,
9 type 2
8 SA to ICA bypass
(all veins)
6 CCA
endarterectomy
1 SA to ECA
bypass (vein)
9 not revascularized
(type 2)
NA 1 patient
continued
TIAs on the
reconstructed
side
1 asymptomatic
late occlusion of
a SA-carotid
bypass
Collice et al.
(1983)3
9 Mean
55 y/8 M
3 TIAs, 4
stroke, 2
circulatory
insufﬁciency
8 Lt
1 Rt
1 1A, 8 1B
4 SA to ECA bypass
4 CCA endarterectomy
1 CCA to ECA
bypass (Dacron)
Mean 14.0 1 perioperative
stroke
Podore et al.
(1981)9
5 NA 3 circulatory
insufﬁciency,
1 TIA,
1 stroke
4 1A
1 1B
3 SA to carotid
bif bypass
2 Ax to carotid
bif bypass
NA None
Note. NA ¼ not available; F ¼ female; M ¼ male; TIA ¼ transient ischemic attack; Lt ¼ left; Rt ¼ right; VA ¼ vertebral artery;
ICA ¼ internal carotid artery; Bil ¼ bilateral; CCA ¼ common carotid artery; SA ¼ subclavian artery; ECA ¼ external carotid artery;
MCA ¼ middle cerebral artery; Ax ¼ axillary artery; PTFE ¼ polytetraﬂuoroethylene; CEA ¼ carotid endarterectomy; bif ¼ bifurcation;
PTA ¼ percutaneous transluminal angioplasty; MI ¼ myocardial infarction.
Table 2. Bypass procedures in relation to Rile’s classiﬁcation.
Rile’s classiﬁcation Bypass procedure n (%)
1A SA-ICA 17 (23.0)
SA-CCA 3 (4.1)
SA-ECA 8 (10.7)
Ax-ICA 12 (16.1)
Ax-CCA 6 (8.1)
Ax-ECA 8 (10.7)
Other 4 (5.3)
1B SA-ECA 9 (12.2)
Ax-ECA 1 (1.4)
CCA-ECA 1 (1.4)
Other 1 (1.4)
2 VA-MCA 2 (2.8)
SA-ECA (distal) 2 (2.8)
Total 74.0
Note. SA ¼ subclavian artery; ICA ¼ internal carotid artery;
CCA ¼ common carotid artery; ECA ¼ external carotid artery;
Ax ¼ axillary artery; VA ¼ vertebral artery; MCA ¼ middle
cerebral artery.
294 European Journal of Vascular and Endovascular Surgery Volume 46 Issue 3 Month/2013(5.1%) transpositions (six CCA to subclavian artery [SA] and
one ECA to ICA), while only one (0.8%) patient underwent
an endovascular procedure.
In bypasses, the most common inﬂow vessel was the SA
(73 patients, 64.1%) and was anastomosed (50.7%) to the
CCA in nearly half of the patients (Table 2). The axillary
artery was used as the inﬂow vessel in 27 (23.7%) patients
and was anastomosed equally to the CCA, ICA, and ECA.
Detailed data for the choice of conduit was available in 104
patients. In 59 patients a veindusually the great saphe-
nousdwas used as a conduit for the accomplishment of the
bypass, while in 41 the conduit was synthetic. In the
remaining four patients an arterial segment was used as the
conduit. The detailed relation of the bypass procedure with
the DSA ﬁndings according to Rile’s classiﬁcation was
available in half of the patients (74, 54%), (Table 2). In type
1A the conduit was anastomosed to the ICA in half of the
patients, while in type 1B the ECA was chosen as the
outﬂow vessel in all patients.
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Two symptomatic patients suffered a stroke during the ﬁrst
30 days after CCAO treatment, yielding a 1.5% procedural
stroke risk; no transient ischemic attacks (TIAs) were
documented during the same time period (Table 3). There
were no deaths related to any cerebrovascular event during
the 30 days after the procedure.
During a follow-up period averaging 25.6  11.2 months
(range 2e110) nine patients experienced a clinical cere-
brovascular event. Three patients (2.2%) had an ipsilateral
stroke at 4, 96, and 103 months after the procedure. The
stroke was fatal in one patient, while in the other two the
angiographic examination revealed a patent graft. Six pa-
tients (4.3%) experienced ipsilateral TIAs at a time ranging
from 12 to 84 months after the procedure. Angiographic
examination revealed a patent graft in four of the patients,
while the remaining two had a signiﬁcant stenosis at the
proximal anastomosis.
Seven restenosis (5.1%) developed during the follow-up
perioddsix after open surgical procedure and one after
endovascular repair. Two of these restenosis were symp-
tomatic, two were asymptomatic, and no sufﬁcient data
were available for the remaining three patients. Two reoc-
clusions (1.5%), one symptomatic and one asymptomatic
occurred during the same period.
DISCUSSION
CCAO is a rare condition that may be associated with stroke,
TIA, or chronic cerebral ischemia. Literature data concerning
the best medical treatment of total CCAO are scarce.
Considering the current literature, and as no randomized
controlled trials exist, any speculation about the necessity
of an intervention and any possible beneﬁt from best
medical treatment remains an assumption that has to be
proven in the future. The results of all the studies reviewed
suggest that surgical revascularization may be a relatively
safe therapeutic approach for treating CCAO with low rates
of periprocedural stroke or death, but with questionable
beneﬁt.
Diagnosis
All patients in this review were studied preoperatively with
angiography. However, detailed information regarding
collateral ﬁlling and ﬂow was available in few studies.
Neither computed tomography angiography nor magnetic
resonance angiography can document the dynamic pattern
of collateral ﬂow to reconstitute a patent carotid bifurcationTable 3. Pooled clinical outcomes of all patients treated for
common carotid artery occlusion.
Cerebrovascular events
Strokes at 30 days 2 (1.5%)
TIAs at 30 days 0 (0%)
Events in follow-up 9 (6.6%)
Restenosis 7 (5.1%)
Reocclusion 2 (1.5%)
Note. TIA ¼ transient ischemic attack.in the setting of CCAO.34 Color duplex sonography appears
to be a sensitive method for evaluating the patency of the
ICA and ECA beyond an occluded CCA, allowing further
investigation with selective arteriography.35 The reconsti-
tution of carotid bifurcation via the collateral vessels, as
well as the patency of ICA intracranially, may be adequately
evaluated in cerebral angiography. However, DSA does not
provide quantitative information on actual brain perfusion.
Arterial spin-labeling magnetic resonance imaging can
noninvasively document the presence and intensity of
collateral ﬂow in patients with cerebrovascular disease, and
may replace the diagnostic DSA in selected groups of pa-
tients with CCAO.36 Despite the lack of sufﬁcient evidence,
it seems reasonable that determining precisely the pres-
ence and adequacy of collateral blood ﬂow is of utmost
importance in order to select patients who may beneﬁt
from a revascularization procedure.Symptomatic
Unfortunately, there is limited natural history data for pa-
tients who present with CCAO. The vast majority (92.7%) of
patients treated were symptomatic, while TIAs were more
common than strokes. As most patients were symptomatic
it is rather difﬁcult to acknowledge a type, according to
Rile’s classiﬁcation, that may be innocent and does not
warrant treatment. However, some information can be
drawn from this review. Rile’s type 1C occlusion is a purely
theoretical variant that has been met neither in our practice
nor in this review. Furthermore, Riles et al.11 included in
their report nine patients with type 2 CCAO that were
deemed inoperable. We found only four additional patients
with type 2 CCAO that were operated ondtwo with an
exotic bypass (vertebral artery-middle cerebral artery) and
two with a subclavian-to-distal ECA bypass. In patients with
occlusion of the whole carotid tree (type 2), surgical inter-
vention consists of a controversial approach of doubtful
necessity, and might be considered only in exceptional
symptomatic patients that will beneﬁt from a revasculari-
zation procedure. Unfortunately, the vast majority of the
articles did not provide detailed data concerning the exact
time of the intervention in relation to the neurologic event.
The delay of a revascularization procedure months after the
event could be proved of no beneﬁt. This could be espe-
cially important in patients with type 1B pattern (only ECA
patent) once the contralateral ICA and vertebral arteries are
patent.
Traditionally, the aim of surgical treatment in patients
with cerebrovascular ischemic syndrome is the prevention
of stroke. However, in case of cerebral insufﬁciency owing
to CCAO the surgical procedure also has a therapeutic goal
by improving the brain circulation and functionality. Inter-
estingly, in this review, all patients undergoing surgery for
transient non-hemispheric symptoms due to circulatory
insufﬁciency had their symptoms resolved after the
procedure.
The natural history of CCAO in asymptomatic patients is
unknown. Only 6% of the patients included in this review
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has not been proven.37,38 Pending a deﬁnite trial result and
as current surgical experience is based on treating symp-
tomatic disease, it seems that best medical treatment
consists of a reasonable ﬁrst-line therapy for patients with
asymptomatic CCAO.
Bypass
The vast majority of the patients treated underwent a
bypass surgical procedure. The ipsilateral SA served as the
donor vessel in most of the cases, followed by the axillary
artery. Fry et al.15 reported the largest series of SA-carotid
artery bypass demonstrating excellent patency rates. The
axillary artery, although second in selection as a donor
vessel, may have some advantages for both ease of expo-
sure and anastomosis, especially as it also avoids injuring
important surrounding structures. However, Archie et al.10
reported three restenoses in 23 symptomatic patients
treated with axillary-to-carotid artery bypass, without
providing detailed data about the events, however.10
The choice of the conduit for the accomplishment of the
bypass varied. In nearly half of the patients undergoing a
bypass procedure a vein graft was applied, followed by a
synthetic one in one third. Ziomek et al.32 by including both
carotidesubclavian and subclavianecarotid bypasses found
that the prosthetic graft offered better results when
compared with vein graft, probably because of a better
resistance to kinking.32 This review did not show any dif-
ference between the two grafts, indicating that both are
acceptable with good long-term results. Furthermore, from
the nine cerebrovascular events occurred during the follow-
up, only two seemed to be associated graft stenosis or
occlusion, meaning that patency of the bypass should not
be linked with freedom from ipsilateral cerebrovascular
event.
Rare techniques
The transposition of the CCA to the SA has been performed
in six patients, with one of them developing a signiﬁcant
stenosis at 19 months after. Although this technique ac-
complishes a direct revascularization with use of the
autogenous artery, it is not always applicable, as it often
requires additional thrombo-endarterectomy of the
occluded CCA, as well as the absence of signiﬁcant disease
in the ipsilateral SA.
Furthermore, common carotid endarterectomy was per-
formed in nearly 10% of the patients. In these cases it is
very important always to secure a “sound” proximal CCA
end. Obviously, if the occlusion of the CCA extends as far as
its origin, direct CEA is of limited use, especially in left CCA
owing to more complex access.22
Endovascular
Endovascular procedure has been performed in only one
patient (0.9%) with CCAO, showing that the use of such an
approach has not yet been introduced in these cases.
Despite the development of newer endovascular devicesand constantly growing operator experience, endovascular
recanalization of a chronic carotid occlusion is a therapeutic
ﬁeld with limited knowledge. Current data regarding the
endovascular repair of carotid chronic occlusion comes
mostly from few cases involving the ICA.39 Despite the
promising short-term results these reports lack sufﬁcient
data to determine the ultimate place of this approach
among other therapies. Chronic atherosclerotic plaque of
CCA is usually bulky, calciﬁed and so the technique is often
limited by the inability of the guidewire to cross these
occlusive lesions, especially when they comprise the entire
length of the CCA. Furthermore the procedural risks, such
as embolic stroke, are completely unknown. Based on cur-
rent knowledge, this therapeutic approach is not justiﬁed
and may be considered only for extremely high-risk patients
with signiﬁcant co-morbidities that are completely unﬁt for
any open procedure.
This review has several limitations. Heterogeneity in the
procedures performed and the wide range in the length
follow-up comprise a limitation in the analysis of the
outcome. Our literature data are mostly from case reports
and relatively small case series consisting of patients who
were not prospectively followed. Surgical series also have,
inherently, a referral bias, as some cases are often treated
conservatively and may not ever refer to a surgeon for in-
clusion in studies. Selection bias, as clinicians usually report
on those patients with the best outcomes, as well as the
limited number of patients and the wide range of the
publication’s year of the articles, should be acknowledged.
Furthermore, assessment of the quality of the reviewed
publications with a formal process (e.g., Preferred Reporting
Items for Systematic Reviews and Meta-Analyses) was not
applicable owing to lack of randomized trials and poor
quality of the published series and reports, although such a
process would improve the level of evidence extracted by
our review.
The present review reﬂects the bulk of the current data
on surgical management of CCAO. It is clear that there are
insufﬁcient data on the natural history of CCAO and its
relation to the occurrence of a cerebrovascular event. The
necessity of intervening in a CCAO remains controversial.
The rarity of such a situation and the dearth of clear evi-
dence support the need for a larger multicenter registry.
This review shows that open surgical management of
symptomatic CCA occlusive disease is a safe, durable, and
effective therapeutic strategy with low perioperative cere-
brovascular morbidity. The question remains, however, as to
how long-term outcomes differ between symptomatic pa-
tients treated surgically for CCAO disease and those
receiving optimal medical management for CCAO disease.FUNDING
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